In today’s session Molina Healthcare, Inc. (MOH) registered an unusually high (1,514) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the December, 2016 call, expecting serious MOH increase. With 1,514 contracts traded and 25044 open interest for the Dec, 16 contract, it seems this is a quite bullish bet. The option with symbol: MOH161216C00055000 closed last at: $1.75 or 25% up. The stock increased 1.08% or $0.56 on November 23, hitting $52.56. Molina Healthcare, Inc. (NYSE:MOH) has declined 19.21% since April 22, 2016 and is downtrending. It has underperformed by 24.62% the S&P500.
Analysts await Molina Healthcare, Inc. (NYSE:MOH) to report earnings on February, 13. They expect $0.75 EPS, up 15.38% or $0.10 from last year’s $0.65 per share. MOH’s profit will be $43.09 million for 17.52 P/E if the $0.75 EPS becomes a reality. After $0.85 actual EPS reported by Molina Healthcare, Inc. for the previous quarter, Wall Street now forecasts -11.76% negative EPS growth.
Molina Healthcare, Inc. (NYSE:MOH) Ratings Coverage
Out of 11 analysts covering Molina Healthcare (NYSE:MOH), 4 rate it a “Buy”, 2 “Sell”, while 5 “Hold”. This means 36% are positive. Molina Healthcare has been the topic of 18 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The stock of Molina Healthcare, Inc. (NYSE:MOH) has “Outperform” rating given on Monday, May 2 by Leerink Swann. On Thursday, September 3 the stock rating was maintained by Cantor Fitzgerald with “Hold”. The firm has “Neutral” rating by Credit Suisse given on Wednesday, December 16. The stock of Molina Healthcare, Inc. (NYSE:MOH) has “Equal Weight” rating given on Monday, November 2 by Barclays Capital. As per Friday, November 11, the company rating was downgraded by Credit Suisse. JP Morgan initiated the shares of MOH in a report on Wednesday, September 16 with “Neutral” rating. The rating was upgraded by Goldman Sachs on Monday, September 19 to “Neutral”. The stock of Molina Healthcare, Inc. (NYSE:MOH) has “Underperform” rating given on Friday, April 29 by Bank of America. As per Tuesday, September 13, the company rating was maintained by Jefferies. Goldman Sachs downgraded it to “Sell” rating and $45 target price in Wednesday, May 4 report.
According to Zacks Investment Research, “Molina Healthcare is a multi-state managed care organization that arranges for the delivery of healthcare services to persons eligible for Medicaid and other programs for low-income families and individuals. It currently operates health plans in California, Washington, Michigan and Utah.”
Insitutional Activity: The institutional sentiment increased to 1.17 in Q2 2016. Its up 0.07, from 1.1 in 2016Q1. The ratio increased, as 58 funds sold all Molina Healthcare, Inc. shares owned while 76 reduced positions. 46 funds bought stakes while 101 increased positions. They now own 49.13 million shares or 7.28% less from 52.99 million shares in 2016Q1.
The Washington-based Parametric Port Assocs Ltd Limited Liability Company has invested 0.01% in Molina Healthcare, Inc. (NYSE:MOH). Arrowgrass Capital Prns (Us) Limited Partnership last reported 110,000 shares in the company. Prudential accumulated 220,609 shares or 0.02% of the stock. Rdl Fin Inc has invested 0.17% of its portfolio in Molina Healthcare, Inc. (NYSE:MOH). Arrowgrass Cap Prns Limited Liability Partnership owns 250,000 shares or 4.73% of their US portfolio. Retirement Sys Of Alabama has invested 0.02% of its portfolio in Molina Healthcare, Inc. (NYSE:MOH). Stoneridge Investment Prtnrs Limited Liability Company has 32,654 shares for 0.24% of their US portfolio. Parkwood Ltd Liability Company has 6,614 shares for 0.06% of their US portfolio. Walleye Trading Ltd Com last reported 0% of its portfolio in the stock. Moreover, Victory Cap Mngmt has 0.15% invested in Molina Healthcare, Inc. (NYSE:MOH) for 728,913 shares. Blackrock Mgmt holds 268,801 shares or 0.02% of its portfolio. Gemmer Asset Mngmt Limited Liability Company has 0% invested in the company for 59 shares. State Treasurer State Of Michigan has 0.01% invested in the company for 16,600 shares. National Bank & Trust Of Montreal Can last reported 279,972 shares in the company. Geneva Ltd Liability last reported 0.01% of its portfolio in the stock.
Insider Transactions: Since July 28, 2016, the stock had 0 buys, and 13 sales for $3.49 million net activity. Another trade for 750 shares valued at $41,250 was sold by ROMNEY RONNA. BAYER TERRY also sold $469,500 worth of Molina Healthcare, Inc. (NYSE:MOH) shares. Shares for $1.50M were sold by MOLINA JOHN C. Shares for $147,050 were sold by ORLANDO STEVEN J. The insider WHITE JOSEPH W CPA sold 6,676 shares worth $390,399. Another trade for 1,600 shares valued at $88,736 was sold by Carruthers Garrey. $145,925 worth of shares were sold by Murray Frank E MD on Monday, August 8.
Molina Healthcare, Inc. offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The company has a market cap of $3.02 billion. The Firm operates through three divisions: Health Plans, Molina Medicaid Solutions and Other. It has a 23.2 P/E ratio. The Company’s Health Plans segment consists of health plans in approximately 10 states and the Commonwealth of Puerto Rico, and its direct delivery business.
MOH Company Profile
Molina Healthcare, Inc., incorporated on July 24, 2002, offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Firm operates through three divisions: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business. It arranges healthcare services for its members through contracts with providers that include independent physicians and groups, hospitals, ancillary providers and its own clinics. The Company’s network of providers includes primary care physicians, specialists and hospitals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.